🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Study of the Factors Favoring the Transition From Prediabetes to Diabetes on Reunion Island.

RecruitingNAAges 25 Years - 70 YearsAllCentre Hospitalier Universitaire de la Réunion
NCT04463160 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The management of diabetes and its complications in Reunion island is one of the priority areas of health. Indeed, the impact of diabetes on the health of the Reunion island population is major: the prevalence of diabetes treated in Reunion island is the highest in France (10% of the population), and gestational diabetes is found in 10% of pregnancies. Reunionese diabetics develop severe complications, in particular cardiovascular (strokes, myocardial infarction). This results in 3 times higher mortality linked to diabetes on Reunion Island, in particular among those under 65 years of age. Despite all the screening and prevention programs put in place, the weight of diabetic disease continues to increase in our island, and this is more accelerated than in the other French departments with 4,300 new cases of diabetes / year, 95% of which type 2 diabetics (T2D). The presentation of type 2

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Subject aged 25 to 70 with pre-diabetes defined by fasting blood sugar between 1.10 and 1.25 g / l (6.1 and 6.9 mmol / l) or blood sugar between 1.40 and 1.99 g / l (7.8 and 11.0 mmol / l) 2 hours after taking 75g of glucose (HGPO test), dating from less than 3 months. * Consulting one of the general practitioners involved in the study, whatever the initial reason for the consultation * able to answer a telephone survey questionnaire * who have never been diagnosed or treated for diabetes with the exception of gestational diabetes * Person affiliated or beneficiary of a social security scheme. * Free, informed and written consent signed Exclusion Criteria: * People likely to leave Reunion within 2 years * Persons placed under guardianship, curators, safeguard of justice, person participating in another research including an exclusion period still in progress. * Person with severely impaired physical and / or psychological health, who, according to the investigator, may affect the compliance of the study participant. * Pregnancy in progress
💊

What it tests

  • prevention program for prediabetes "Say No to Diabetes"
📍

Where

1 site
Centre Hospitalier Universitaire de la Réunion
Saint-Pierre, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy